GE, InSightec ink new deal

GE Healthcare has signed a new worldwide sales and marketing agreement with InSightec Image Guided Treatment for the Tirat Carmel, Israel-based vendor's ExAblate 2000 MRI-guided focused ultrasound treatment system.

GE will hold exclusive worldwide distribution rights for the uterine fibroid treatment unit, except for Japan and Russia. InSightec has existing distributors and representatives in those countries.

Under the five-year agreement, InSightec and GE of Chalfont St. Giles, U.K., will also collaborate on research and development and marketing.

By staff writers
August 17, 2005

Related Reading

GE adds to VHA contract, August 5, 2005

GE revenues climb in Q2, July 18, 2005

GE adds RIS/PACS contract, July 14, 2005

MRI-guided ultrasound therapy relieves fibroid symptoms, December 14, 2004

GE partners with Insightec, October 25, 2004

Copyright © 2005

Page 1 of 57
Next Page